Piramal Pharma Limited (PPLPHARMA)
₹254.4
INR-2.95(-1.15%)
As of December 27, 2024 9:59:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹35206.47 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹40063.56 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
701.97
Forward P/E
Price to Earnings ratio based on forecasted earnings
55.60
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
4.04
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
64.47%
Operating Margin
Operating income as a percentage of revenue
6.66%
Return on Equity
Net income as a percentage of shareholders' equity
0.58%
Revenue (TTM)
Total revenue over trailing 12 months
₹8703.82 Cr+17.299999999999997%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1548.51 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹0.38+350%
Balance Sheet
Total Cash
Total cash and short-term investments
₹408.41 Cr
Total Debt
Total short-term and long-term debt
₹4786.41 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
60.53%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹114.35 - ₹307.9
Beta
Measure of stock's volatility compared to the market
0.08
Shares Outstanding
Total number of shares issued by the company
₹131.98 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.17%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
28.21%